文献速递妇科产科

精准预防:基于BRCA1/2簇区突变类型确定降低风险输卵管卵巢切除术的最佳时机

Precision prophylaxis: Identifying the optimal timing for risk-reducing salpingo-oophorectomy based on type of BRCA1 and BRCA2 cluster region mutations.
PubMed 文献 · Gynecol Oncol · 2020-01-07

该研究用马尔可夫模型模拟BRCA1/2突变患者,评估不同簇区突变(OCCR、BCCR、非BCCR/OCCR)、诊断年龄和RRSO年龄下的平均预期寿命。结果显示所有突变类型均宜尽早行RRSO,延迟时OCCR突变者预期寿命损失更大,RRSO时机需个体化决策。

要点

  • 所有BRCA1/2突变类型的最佳策略均为尽早行RRSO。
  • 延迟RRSO时OCCR突变者预期寿命低于BCCR及非BCCR/OCCR突变者。
  • RRSO时机需结合簇区突变类型个体化决策。

核心结论

  • BRCA1/2簇区突变可用于更精准的预期寿命评估,辅助咨询与共享决策。
  • RRSO最佳时机是复杂决策,必须对每位患者个体化制定。

研究设计与样本

  • 采用假设性BRCA1/2突变患者队列构建马尔可夫模型,估计平均预期寿命。
  • 模型变量包括BRCA1/2突变、簇区突变类型(OCCR、BCCR或非BCCR/OCCR)、诊断年龄20-65岁及RRSO年龄21-80岁。

主要发现

  • 对所有BRCA1/2突变类型,最佳策略均为尽早行RRSO。
  • 延迟RRSO或较晚发现突变者中,OCCR突变者的预期寿命估计低于BCCR和非BCCR/OCCR突变者。
  • RRSO延迟幅度小(相邻5年间隔)时,预期寿命损失较小。
  • 对预期寿命影响最大的变量包括RRSO后卵巢癌风险、乳腺癌死亡率、RRSO相关非癌死亡率和乳腺癌分期分布。

临床怎么用

  • 咨询中可结合BRCA1/2簇区突变类型提供更精准的预期寿命信息。
  • RRSO时机应基于突变类型、诊断年龄等因素与患者共享决策、个体化确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Current risk-reducing salpingo-oophorectomy (RRSO) guidelines for individuals with BRCA1/2 mutations do not account for risk variability due to BRCA1/2 cluster region mutations that are associated with varying risks for the development of breast and ovarian cancer. We assessed whether current recommendations are appropriate for individual patients considering mutation-specific risks. METHODS: Using a hypothetical cohort of patients with BRCA1/2 mutations, we constructed Markov models allowing for the estimation of mean life expectancy based upon BRCA1/2 mutation, the presence of a cluster region mutation (Ovarian Cancer Cluster Region (OCCR), Breast Cancer Cluster Region (BCCR), or non-BCCR/OCCR), age at time of BRCA1/2 diagnosis (20-65), and age at time of RRSO (21-80). RESULTS: For all BRCA1/2 mutation types, the optimal strategy was to undergo RRSO as early as possible. For BRCA1/2 carriers who delayed RRSO or who were identified with a mutation later in life, the OCCR mutation tended to be associated with lower life expectancy estimates than the BCCR and non-BCCR/OCCR mutations. Minimal delays in RRSO (i.e., neighboring 5-year intervals) were associated with minor losses in life expectancy. Variables associated with greatest impact on life expectancy included ovarian cancer risk after RRSO, breast cancer mortality rate, non-cancer mortality associated with RRSO, and breast cancer stage distribution. CONCLUSIONS: BRCA1/2 cluster regions may provide more precise estimates of life expectancy in counselling and shared decision-making. The most appropriate timing for RRSO is a complex decision and must be individualized for each patient.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Solsky I, Chen J, Rebbeck TR, et al. Precision prophylaxis: Identifying the optimal timing for risk-reducing salpingo-oophorectomy based on type of BRCA1 and BRCA2 cluster region mutations. Gynecol Oncol. 2020. PMID: 31918993. doi:10.1016/j.ygyno.2019.11.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。